Turning clinical observations into real-world evidence (RWE) is influencing how therapies are validated and brought to ...

The US Food and Drug Administration (FDA) is offering a detailed look at how real-world evidence sources – from registries to claims data – can be used to support marketing applications for medical ...

The fight against cancer is complex and multifaceted, requiring a collective effort to create transformative change. There is a vast opportunity for collaboration to spark discussions and advance ...

From the rise of ChatGPT to the passage of the Inflation Reduction Act (IRA), the landscape that surrounds real-world evidence (RWE) is changing rapidly, and use of RWE is evolving right along with it ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

Phase 3 randomized controlled trials (RCTs), while the gold standard for treatment efficacy and safety, are not always feasible, are expensive, can be prolonged and can be limited in generalizability.

Suggested Citation: "3 Opportunities for Real-World Data." National Academies of Sciences, Engineering, and Medicine. 2017. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings ...

Real-world evidence (RWE) has long held the promise of transforming how we understand cancer—turning the reality of everyday patient care into insights that inform research, clinical development, ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...

A clinical trial conducted by Dr James Lind in the year 1747 on patients with scurvy, made the basis of modern-day RCTs. Since then, there have been many advancements in the art and science of ...

Healthcare systems worldwide are facing unprecedented pressure, from the rise in chronic diseases and aging populations to fragmented healthcare and over-stretched resources. The result? Delayed, ...

MEDDDICAL has launched a real-world evidence analytics and advisory service, offering structured guidance to pharmaceutical and MedTech companies at a time when real-world evidence requirements from ...